1921
Volume 87, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Disseminated histoplasmosis is an emerging infection in patients with cellular immune deficiency in non-endemic countries, caused by the migration from endemic regions and the development of travels. Diagnosis can be challenging in this context because rapid diagnostic tools such as antigen detection or appropriate molecular tools are generally unavailable, serology is often negative in immunosuppressed patients, and isolation of the fungus from cultures often takes several weeks. Here, we report the contribution of galactomannan serum detection for the management of an HIV-infected patient with disseminated histoplasmosis.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2012.12-0119
2012-08-01
2017-11-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/87/2/303.html?itemId=/content/journals/10.4269/ajtmh.2012.12-0119&mimeType=html&fmt=ahah

References

  1. Versalovic J, Brant ME, Johnson EM, , 2011. Histoplasm, Blastomyces, Coccidioides, and other dimorphic fungi causing systemic mycoses. , eds. Manual of Clinical Microbiology. Tenth edition. Washington, DC: ASM Press, 19021918.[Crossref]
  2. Kauffman CA, , 2007. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20: 115132.[Crossref]
  3. Antinori S, Magni C, Nebuloni M, Parravicini C, Corbellino M, Sollima S, Galimberti L, Ridolfo AL, Wheat LJ, , 2006. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) 85: 2236.[Crossref]
  4. Peigne V, Dromer F, Elie C, Lidove O, Lortholary O, The F, , 2011. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy ras. Am J Trop Med Hyg 85: 934941.[Crossref]
  5. Ashbee HR, Evans EG, Viviani MA, Dupont B, Chryssanthou E, Surmont I, Tomsikova A, Vachkov P, Enero B, Zala J, Tintelnot K, , 2008. Histoplasmosis in Europe: report on an epidemiological survey from the European Confederation of Medical Mycology Working Group. Med Mycol 46: 5765.[Crossref]
  6. Warnock DW, Dupont B, Kauffman CA, Sirisanthana T, , 1998. Imported mycoses in Europe. Med Mycol 36 (1 Suppl): 8794.
  7. Dupont B, Crewe Brown HH, Westermann K, Martins MD, Rex JH, Lortholary O, Kauffmann CA, , 2000. Mycoses in AIDS. Med Mycol 38 (Suppl 1): 259267.[Crossref]
  8. Wheat LJ, , 2006. Improvements in diagnosis of histoplasmosis. Expert Opin Biol Ther 6: 12071221.[Crossref]
  9. Buitrago MJ, Bernal-Martinez L, Castelli MV, Rodriguez-Tudela JL, Cuenca-Estrella M, , 2011. Histoplasmosis and paracoccidioidomycosis in a non-endemic area: a review of cases and diagnosis. J Travel Med 18: 2633.[Crossref]
  10. Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, Kauffman CA, , 2007. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 45: 807825.[Crossref]
  11. Breton G, Adle-Biassette H, Therby A, Ramanoelina J, Choudat L, Bissuel F, Huerre M, Dromer F, Dupont B, Lortholary O, , 2006. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 20: 119121.[Crossref]
  12. Wheat LJ, Hackett E, Durkin M, Connolly P, Petraitiene R, Walsh TJ, Knox K, Hage C, , 2007. Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol 14: 638640.[Crossref]
  13. Narreddy S, Chandrasekar PH, , 2008. False-positive Aspergillus galactomannan (GM) assay in histoplasmosis. J Infect 56: 8081.[Crossref]
  14. Jones O, Cleveland KO, Gelfand MS, , 2009. A case of disseminated histoplasmosis following autologous stem cell transplantation for Hodgkin's lymphoma: an initial misdiagnosis with a false-positive serum galactomannan assay. Transpl Infect Dis 11: 281283.[Crossref]
  15. Kauffman CA, , 2008. Diagnosis of histoplasmosis in immunosuppressed patients. Curr Opin Infect Dis 21: 421425.[Crossref]
  16. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL, , 2005. Evaluation of a (1 → 3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43: 59575962.[Crossref]
  17. Egan L, Connolly P, Wheat LJ, Fuller D, Dais TE, Knox KS, Hage CA, , 2008. Histoplasmosis as a cause for a positive Fungitell (1 → 3)-beta-D-glucan test. Med Mycol 46: 9395.[Crossref]
  18. Koga M, Koibuchi T, Kikuchi T, Nakamura H, Miura T, Iwamoto A, Fujii T, , 2011. Kinetics of serum beta-D-glucan after Pneumocystis pneumonia treatment in patients with AIDS. Intern Med 50: 13971401.[Crossref]
  19. Watanabe T, Yasuoka A, Tanuma J, Yazaki H, Honda H, Tsukada K, Honda M, Gatanaga H, Teruya K, Kikuchi Y, Oka S, , 2009. Serum (1 → 3) beta-D-glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS. Clin Infect Dis 49: 11281131.[Crossref]
  20. Lefort A, Chartier L, Sendid B, Wolff M, Mainardi JL, Podglajen I, Desnos-Ollivier M, Fontanet A, Bretagne S, Lortholary O, , 2012. Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect 18: E99E109.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2012.12-0119
Loading
/content/journals/10.4269/ajtmh.2012.12-0119
Loading

Data & Media loading...

  • Received : 21 Feb 2012
  • Accepted : 10 Apr 2012

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error